For screening-adherent members, directly mailing HPV kits was more effective and cost-saving than usual care
WEDNESDAY, Oct. 8, 2025 (HealthDay News) — Direct-mail human papillomavirus (HPV) self-test kits boost screening rates and are cost-effective, according to a study published online Oct. 1 in JAMA Network Open.
Richard T. Meenan, Ph.D., from Kaiser Permanente Northwest in Portland, Oregon, and colleagues conducted an economic evaluation of mailed HPV self-sampling (direct-to-all or opt-in) versus usual care among members of a U.S. health care system. The analysis included 31,355 individuals.
The researchers found that among screening-adherent members, direct mail was the most effective and cost-saving strategy. For overdue members, direct mail was also more effective than usual care and generated an additional completed screen at a cost ranging from −$19 (cost saving) to $63, depending on cost basis and visit type. Among members with unknown adherence, opt-in was generally more effective and cost-saving than usual care. Although the screening-adherent subgroup had the largest year 1 program budget, its budget declined fastest and was lowest by year 4. The smallest annual budget decreases were seen among eligible individuals with unknown adherence history.
“Our findings provide a strong economic justification for health systems to implement mailed HPV self-sampling within their cervical cancer programs, especially since they can reach a wide range of patients,” lead author Rachel L. Winer, Ph.D., from Kaiser Permanente Washington Health Research Institute in Seattle, said in a statement.
Odds of HPV-Related Cancers Up for People With HIV, Solid Organ Transplant Recipients 
Reduced Risk for Invasive Cervical Cancer Persists After HPV Vaccination 
Thyroid Eye Disease Tied to Higher Prevalence of Human Papillomavirus 
Geographic Variation Seen in Declines in Cervical Cancer Incidence 
Colorectal Cancer Risen to Leading Cause of Cancer Death in Men Under 50 
